Renalytix AI plc (LSE:RENX) — Stock Price
Renalytix AI plc (LSE:RENX) is currently trading at GBX4.55 GBX, up 22.97% today. Over the past 52 weeks, shares have ranged between GBX1.80 and GBX10.75. This page tracks Renalytix AI plc's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Renalytix AI plc stock valuation.
Renalytix AI plc (RENX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Renalytix AI plc's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Renalytix AI plc Income Statement — Revenue, Profit & Earnings by Year
Renalytix AI plc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | GBX3.00 Million | GBX2.29 Million | GBX59.60 Billion | GBX3.40 Million | GBX2.97 Million |
| Cost of Revenue | GBX1.80 Million | GBX2.13 Million | GBX34.43 Billion | GBX2.70 Million | GBX2.05 Million |
| Gross Profit | GBX1.20 Million | GBX156.00K | GBX25.18 Billion | GBX701.00K | GBX918.00K |
| Research & Development | GBX900.00K | GBX9.39 Million | GBX949.00 Million | GBX14.30 Million | GBX14.65 Million |
| SG&A | GBX4.90 Million | GBX19.75 Million | GBX6.59 Billion | GBX43.06 Million | GBX12.95 Million |
| Total Operating Expenses | GBX18.40 Million | GBX29.76 Million | GBX15.20 Billion | GBX43.06 Million | GBX58.29 Million |
| Operating Income | GBX-17.20 Million | GBX-29.61 Million | GBX10.07 Billion | GBX-42.35 Million | GBX-53.18 Million |
| EBITDA | GBX-21.30 Million | GBX-28.52 Million | GBX11.06 Billion | GBX-41.71 Million | GBX-52.69 Million |
| EBIT | — | GBX-28.89 Million | GBX9.67 Billion | GBX-42.22 Million | GBX-53.18 Million |
| Interest Expense | GBX500.00K | GBX0.00 | — | GBX2.00K | GBX2.00K |
| Income Before Tax | GBX-21.80 Million | GBX-33.45 Million | GBX9.34 Billion | GBX-45.60 Million | GBX-45.25 Million |
| Income Tax Expense | GBX-1.40 Million | GBX4.00K | GBX2.20 Billion | GBX2.00K | GBX25.00K |
| Net Income | GBX-20.40 Million | GBX-33.46 Million | GBX6.49 Billion | GBX-45.61 Million | GBX-45.28 Million |
Renalytix AI plc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Renalytix AI plc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | GBX6.10 Million | GBX7.97 Million | GBX75.27 Billion | GBX42.12 Million | GBX63.26 Million |
| Total Current Assets | GBX5.80 Million | GBX6.12 Million | GBX17.90 Billion | GBX26.88 Million | GBX44.75 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | GBX100.00K | GBX700.00K | GBX1.11 Billion | GBX1.46 Million | GBX2.74 Million |
| Net Receivables | GBX600.00K | GBX722.00K | GBX4.02 Billion | GBX776.00K | GBX976.00K |
| Inventory | GBX200.00K | GBX300.00K | GBX5.12 Billion | GBX718.00K | GBX1.16 Million |
| Property, Plant & Equipment | — | — | — | GBX1.19 Million | GBX2.56 Million |
| Goodwill | — | — | GBX21.11 Billion | GBX23.14 Billion | GBX23.14 Billion |
| Total Liabilities | GBX13.10 Million | GBX15.83 Million | GBX54.50 Billion | GBX23.66 Million | GBX20.09 Million |
| Total Current Liabilities | GBX4.80 Million | GBX11.49 Million | GBX23.51 Billion | GBX16.13 Million | GBX11.78 Million |
| Long-term Debt | GBX8.30 Million | GBX4.33 Million | — | GBX7.49 Million | GBX7.68 Million |
| Net Debt | GBX4.70 Million | GBX3.85 Million | GBX25.13 Billion | GBX-12.53 Million | GBX-28.63 Million |
| Total Stockholder Equity | GBX-7.00 Million | GBX-7.85 Million | GBX18.10 Billion | GBX6.97 Million | GBX30.61 Million |
| Retained Earnings | GBX-165.10 Million | GBX-211.78 Million | GBX47.05 Billion | GBX-178.32 Million | GBX-132.72 Million |
Renalytix AI plc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Renalytix AI plc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-17.90 Million | GBX-30.11 Million | GBX9.43 Billion | GBX-32.67 Million | GBX-45.74 Million |
| Capital Expenditures | GBX0.00 | GBX4.00K | GBX1.50 Billion | GBX694.00K | GBX694.00K |
| Free Cash Flow | GBX-17.90 Million | GBX-30.11 Million | GBX7.92 Billion | GBX-33.37 Million | GBX-46.44 Million |
| Investing Cash Flow | — | GBX-4.00K | — | — | GBX-662.00K |
| Financing Cash Flow | GBX16.00 Million | GBX10.25 Million | GBX-7.19 Billion | GBX15.12 Million | GBX25.52 Million |
| Dividends Paid | — | — | GBX4.36 Billion | GBX4.64 Billion | GBX5.10 Billion |
| Stock-Based Compensation | GBX3.20 Million | GBX1.71 Million | GBX212.00 Million | GBX1.56 Million | GBX7.01 Million |
| Depreciation | GBX0.00 | GBX364.00K | GBX1.39 Billion | GBX2.49 Million | GBX2.61 Million |
| Change in Cash | GBX-1.10 Million | GBX-20.00 Million | GBX-180.00 Million | GBX-16.65 Million | GBX-23.83 Million |
Renalytix AI plc Earnings History — EPS Actual vs. Analyst Estimates
Track Renalytix AI plc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 16, 2026 | — | — | — |
| Nov 04, 2025 | 0.00 | -0.02 | +100.00% |
| Sep 29, 2025 | — | — | — |
| Jun 17, 2025 | 0.00 | -0.02 | +100.00% |
| Mar 18, 2025 | -0.91 | -0.02 | -5997.33% |
| Oct 01, 2024 | -3.63 | -0.02 | -18059.50% |
| May 15, 2024 | -0.06 | -0.04 | -48.10% |
| Feb 15, 2024 | -0.05 | -0.05 | +12.96% |